Invention Grant
US07645589B2 Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma
有权
使用小眼睑诊断，预后和/或治疗黑色素瘤
- Patent Title: Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma
- Patent Title (中): 使用小眼睑诊断，预后和/或治疗黑色素瘤
-
Application No.: US11943099Application Date: 2007-11-20
-
Publication No.: US07645589B2Publication Date: 2010-01-12
- Inventor: David E. Fisher
- Applicant: David E. Fisher
- Applicant Address: US MA Boston
- Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee Address: US MA Boston
- Agency: Fish & Richardson P.C.
- Main IPC: G01N33/574
- IPC: G01N33/574 ; G01N33/53
Abstract:
Microphthalmia (Mi) while present in melanocytes, a cells and osteoclast, is not normally present in other cells. We have found that Mi is present in the nucleus of melanoma cells. Melanoma can be diagnosed by contacting a malignant cell with a probe for Mi. If the probe identities Mi in the nucleus of the cell, the cell is a melanoma.
Public/Granted literature
- US20080213772A1 USE OF MICROPHTHALMIA FOR DIAGNOSIS, PROGNOSIS AND/OR TREATMENT OF MELANOMA Public/Granted day:2008-09-04
Information query
IPC分类:
